Sumitomo Pharma Co., Ltd.
住友ファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4506
FY2025 · 2026-03-31
| Gross margin | 56.7% |
| Operating margin | 23.7% |
| Net margin | 23.6% |
| Return on equity | 36.5% |
| Return on assets | 13.3% |
| Revenue growth (YoY) | 13.7% |
| EPS (basic) | ¥268.99 |
| EPS growth (YoY) | 352.2% |
| Current ratio | — |
| Equity ratio | 36.4% |
| Book value / share | ¥689.23 |
| Free cash flow | 67,106 M |